環球智能控股(00395.HK)出售生育補充品銷售業務 料錄收益50萬人幣
環球智能控股(00395.HK)公布,公司的全資附屬Forever Triumph與買方Casa Mia Caterers International訂立協議,向對方出售目標公司的51%已發行股本,代價1元。Forever Triumph又同意按代價800萬元轉讓股東貸款予買方;豁免支付未償付利息16.8萬元;及促使集團相關成員公司豁免支付未償付金額19.6萬元。
目標公司主要從事於中國及香港銷售、營銷及分銷華康生物醫學控股(08622.HK)一間附屬所供應的若干產品系列,包括但不限於男女性生育補充品。
出售完成後,Forever Triumph將不再持有目標公司的任何股權。集團預計將錄得出售收益約50萬元人民幣。所得款項將用作一般營運資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.